Wang Julia Aijun
Insider CIK 1860279 · BGNE Chief Financial Officer · LH Chief Financial Officer, EVP
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LH LABCORP HOLDINGS INC. | M Exercise deriv | 2026-02-11 | 2026-02-13 | 860 | — | $0 | 4,964 | SEC↗ |
| LH LABCORP HOLDINGS INC. | F Tax w/h | 2026-02-11 | 2026-02-13 | 245 | $289.89 | $71.0K | 1,817 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise | 2026-02-11 | 2026-02-13 | 860 | — | $0 | 2,062 | SEC↗ |
| LH LABCORP HOLDINGS INC. | A Award deriv | 2026-02-10 | 2026-02-12 | 7,100 | — | $0 | 7,100 | SEC↗ |
| LH LABCORP HOLDINGS INC. | A Award deriv | 2026-02-10 | 2026-02-12 | 2,350 | — | $0 | 5,824 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise deriv | 2026-02-06 | 2026-02-10 | 893 | — | $0 | 3,474 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise | 2026-02-06 | 2026-02-10 | 893 | — | $0 | 1,456 | SEC↗ |
| LH LABCORP HOLDINGS INC. | F Tax w/h | 2026-02-06 | 2026-02-10 | 254 | $277.20 | $70.4K | 1,202 | SEC↗ |
| LH LABCORP HOLDINGS INC. | A Award deriv | 2025-02-11 | 2025-02-13 | 7,800 | — | $0 | 7,800 | SEC↗ |
| LH LABCORP HOLDINGS INC. | A Award deriv | 2025-02-11 | 2025-02-13 | 2,580 | — | $0 | 4,367 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise deriv | 2025-02-06 | 2025-02-10 | 893 | — | $0 | 1,787 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise | 2025-02-06 | 2025-02-10 | 893 | — | $0 | 893 | SEC↗ |
| LH LABCORP HOLDINGS INC. | F Tax w/h | 2025-02-06 | 2025-02-10 | 336 | $247.74 | $83.2K | 557 | SEC↗ |
| LH LABCORP HOLDINGS INC. | A Award deriv | 2024-12-02 | 2024-12-04 | 2,680 | — | $0 | 2,680 | SEC↗ |
| LH LABCORP HOLDINGS INC. | A Award deriv | 2024-12-02 | 2024-12-04 | 8,100 | — | $0 | 8,100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-07-01 | 2024-07-03 | 472 | $143.90 | $67.9K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-24 | 2024-06-26 | 899 | $155.66 | $139.9K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-17 | 2024-06-20 | 154 | $158.24 | $24.4K | 762 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-17 | 2024-06-20 | 195 | $158.58 | $30.9K | 567 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-17 | 2024-06-20 | 253 | $159.00 | $40.2K | 314 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-06-17 | 2024-06-20 | 314 | $159.74 | $50.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2024-06-05 | 2024-06-07 | 256,659 | — | $0 | 256,659 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2024-06-05 | 2024-06-07 | 136,240 | — | $0 | 456,326 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2024-02-29 | 2024-03-04 | 397 | $167.08 | $66.3K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-07-03 | 2023-07-06 | 472 | $179.55 | $84.7K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-06-23 | 2023-06-27 | 840 | $182.85 | $153.6K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-06-20 | 2023-06-20 | 190 | $192.54 | $36.6K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2023-06-15 | 2023-06-20 | 409,058 | — | $0 | 409,058 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2023-06-15 | 2023-06-20 | 107,770 | — | $0 | 342,303 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2023-03-01 | 2023-03-03 | 343 | $240.21 | $82.4K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2022-07-01 | 2022-07-05 | 295 | $158.50 | $46.8K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2022-07-01 | 2022-07-18 | 317 | $158.50 | $50.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2022-06-22 | 2022-06-24 | 589,888 | — | $0 | 589,888 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2022-06-22 | 2022-06-24 | 104,377 | — | $0 | 245,583 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2022-06-17 | 2022-06-21 | 161 | $136.64 | $22.0K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2022-02-28 | 2022-03-02 | 61,750 | — | $0 | 143,299 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-07-01 | 2021-07-01 | 308 | $349.06 | $107.5K | 0 | SEC↗ |